X Financial (XYF)
(Delayed Data from NYSE)
$3.79 USD
-0.04 (-1.04%)
Updated Apr 25, 2024 03:54 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for X Financial Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 678 | 517 | 569 | 336 | 444 |
Cost Of Goods | 404 | 308 | 308 | 317 | 235 |
Gross Profit | 274 | 208 | 261 | 19 | 209 |
Selling & Adminstrative & Depr. & Amort Expenses | 71 | 51 | 55 | 238 | 92 |
Income After Depreciation & Amortization | 202 | 157 | 206 | -219 | 117 |
Non-Operating Income | -5 | 20 | -19 | -26 | -21 |
Interest Expense | NA | 0 | 0 | 0 | 0 |
Pretax Income | 198 | 177 | 187 | -245 | 95 |
Income Taxes | 35 | 56 | 58 | -46 | -13 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 5 | -3 | 1 | -1 | 3 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 167 | 118 | 130 | -201 | 111 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 167 | 118 | 130 | -201 | 111 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 202 | 158 | 207 | -217 | 118 |
Depreciation & Amortization (Cash Flow) | NA | 1 | 1 | 2 | 2 |
Income After Depreciation & Amortization | 202 | 157 | 206 | -219 | 117 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 48.45 | 53.73 | 56.15 | 53.54 | 53.29 |
Diluted EPS Before Non-Recurring Items | 3.59 | 2.21 | 2.31 | -3.74 | 2.10 |
Diluted Net EPS (GAAP) | 3.45 | 2.22 | 2.28 | -3.72 | 2.10 |
Fiscal Year end for X Financial Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 167.98 | 191.46 | 168.30 | 146.33 |
Cost Of Goods | NA | 108.39 | 111.17 | 92.36 | 92.29 |
Gross Profit | NA | 63.68 | 80.29 | 75.94 | 54.04 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 26.37 | 20.70 | 14.62 | 9.77 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 37.31 | 59.59 | 61.32 | 44.27 |
Non-Operating Income | NA | -6.27 | -2.37 | -0.11 | 3.87 |
Interest Expense | NA | NA | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 31.05 | 57.22 | 61.22 | 48.14 |
Income Taxes | NA | 5.31 | 10.17 | 12.00 | 7.65 |
Minority Interest | NA | NA | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 1.92 | 0.53 | 1.30 | 0.92 |
Other Income/Charges | NA | NA | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 26.62 | 47.59 | 50.51 | 41.40 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 26.62 | 47.59 | 50.51 | 41.40 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 49.29 | 49.52 | 48.98 | 49.06 |
Diluted EPS Before Non-Recurring Items | NA | 0.64 | 1.01 | 1.00 | 0.87 |
Diluted Net EPS (GAAP) | NA | 0.54 | 0.96 | 1.03 | 0.85 |